To assess the correlation between KDM6B and estrogen receptor β (ERβ) expression in malignant pleural mesothelioma (MPM). Materials & methods: We evaluated gene expression by in silico analysis of microarray data, real-time PCR and western blot in MPM tumors and cell lines. Results & conclusion: We report a strong positive correlation between the expression of KDM6B and ERβ in MPM tumors and cell lines. We describe that, in hypoxia, the HIF2α-KDM6B axis induces an epithelioid morphology and ERβ expression in biphasic MPM cells with estrogen receptor-negative phenotype. Reduced histone H3K27 tri-methylation confirms KDM6B activity under hypoxic conditions. Importantly, cells treated during reoxygenation with the selective ERβ agonist, KB9520, maintain ERβ expression and the less aggressive phenotype acquired in hypoxia.
Human malignant pleural mesothelioma (MPM) is the most common type of mesothelioma. MPM is an aggressive and treatmentresistant cancer that develops on the pleura. The disease is caused primarily by the inhalation of microscopic asbestos fibers. Once these fibers are inhaled, they become lodged in the lining around the lungs and cause cellular and genetic damage that ultimately can lead to cancer [1] [2] [3] [4] .
The most important factors in MPM prognosis are the stage and histotype of the disease at diagnosis. Among the subtypes of this disease, epithelioid mesothelioma makes up the most cases (50-70%) and offers the most long-term hope and best response to treatment. Sarcomatoid cells are the most aggressive mesothelioma cells in terms of rapid growth and resistance to treatments like chemotherapy. Biphasic mesothelioma is a mix of both epithelial and sarcomatoid cells; the response in patients to treatment and life expectance depend upon the percentages of the epithelial component. A higher ratio of epithelial cells translates into longer survival [5] [6] [7] [8] . Other important prognostic factors include age, sex and smoking history [9, 10] .
Our group demonstrated that estrogen receptor β (ERβ) represents a positive prognostic marker and exerts tumor suppressor function in MPM [11] . More recently, we have published data suggesting that metabolic changes, occurring in hypoxic conditions, promote ERβ expression in ERnegative MPM cells and that its expression and tumor suppressive function are maintained by selective ligand activation [12, 13] . While the HIF pathway represents the first clear link between oxygen availability and the regulation of gene expression in mammals, epigenetic changes, not necessarily linked to HIF, take place under hypoxic conditions [14, 15] .
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Research Article Manente, Pinton, Zonca et al. Gene expression is epigenetically regulated through DNA methylation and covalent chromatin modifications, such as acetylation, phosphorylation, ubiquitination, sumoylation and methylation of histones [16] . In general, methylation at H3K4, H3K36 and H3K79 is associated with gene activation, whereas methylation at H3K9, H3K27 and H4K20 correlates with gene repression [17, 18] .
KDM6B, also called Jmjd3, a member of the family of JmjC histone demethylases, has been identified as a H3K27 demethylases that catalyze the demethylation of H3K27me2/3. KDM6B is involved in several cellular processes, such as differentiation, proliferation, senescence and apoptosis [19] .
In this study, we describe a positive correlation between the expressed levels of KDM6B and the ERβ coding gene in tumor samples from MPM patients. Furthermore, we are the first to demonstrate the role of KDM6B in the control of ERβ expression in MPMderived cells grown either under normoxic or hypoxic conditions.
Materials & methods

Reagents & antibodies
The polyclonal antibodies specific for KDM6B, ERβ, histone H3 tri methyl K27 (H3K27me3), histone H3, and monoclonal antibodies specific for α-tubulin and HIF-2α were purchased from Santa Cruz Biotechnology (CA, USA). Antimouse and antirabbit IgG peroxidase conjugated antibodies and chemical reagents were from Sigma-Aldrich (MO, USA). Enhanced chemiluminescence (ECL), nitrocellulose membranes and protein assay kit were from Bio-Rad (CA, USA). Culture media, sera, antibiotics and LipofectAMINE transfection reagent were from Thermo Fisher (MA, USA). The previously described ERβ selective agonist KB9520 [13, [20] [21] [22] was designed and synthesized by Karo Bio AB (Huddinge, Sweden).
Cell cultures & transfection
The biphasic MSTO-211H cell line was obtained from the Istituto Scientifico Tumori Cell-bank, Genoa, Italy; the epithelioid REN cell line was isolated, characterized and kindly provided by Dr Steven Albelda (University of Pennsylvania, PA, USA). Cells were grown in standard conditions in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS), 100 μg/ml streptomycin and 10 μg/ml penicillin at 37°C in a humidified environment containing 5% CO 2 . Cell cultures under hypoxic conditions were performed in 1% O 2 gas mixture using a modulator incubator chamber. Mycoplasma infection was excluded by the use of Mycoplasma PlusTM PCR Primer Set kit from Stratagene (CA, USA). Cells grown to 80% confluence in tissue culture dishes were transiently transfected with specific siRNAs for KDM6B and for EPAS1 from Qiagen (Hilden, Germany) or with the pCMV-HA-JMJD3 plasmid, gift from Dr Kristian Helin (Addgene plasmid #24167) [23] , using LipofectAMINE reagent as described by the manufacturer.
Multicellular spheroids
Multicellular spheroids were generated in nonadsorbent round-bottomed 96-well plates, as described in [24] . The 96-well plates were coated with a 1:24 dilution of polyHEMA (120 mg/ml) in 95% ethanol and dried at 37°C for 24 h. Before use, plates were sterilized by UV light for 30 min. For generation of multicellular spheroids, 10 3 cells were added into each well of polyHEMA-coated 96-well plate in medium and placed in a 37°C humidified incubator with 5% CO 2 .
After an initiation interval of 24 h, 50% of supernatant was replaced with fresh medium ± KB9520 (at final concentration of 10 nM) every 24 h. Multicellular spheroids were analyzed after 5 days of culture.
Immunofluorescence staining
Cell spheroids were fixed, permeabilized with 0.5% Triton X-100 in phosphate buffered saline (PBS) and blocked in 3% bovine serum albumin (BSA)/PBS 10% FBS. The primary antibodies (mouse anti-HIF-2α and rabbit anti-KDM6B or ERβ; 1:100) were incubated for 2 h at 4°C. The fluorescent secondary antibodies (goat anti mouse and anti rabbit IgG antibodies conjugated with fluorescein isothiocyanate; 1:100) were added and incubated for 1 h at 4°C. The cell nuclei were counter-stained with 4′,6-diamidino-2-phenylindole. Fluorescent images were captured using a Leica MB5000B microscope equipped with a DFC480 R2 digital camera and a Leica Application Suite software.
Cell lysis & immunoblot
Cells were extracted with 1% NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 50 mM Tris-HCl pH 8.5 10 mM EDTA, 10 mM NaF, 10 mM Na 4 P 2 O 7 , 0.4 mM Na 3 VO 4 ) with freshly added protease inhibitors (10 μg/ml leupeptin, 4 μg/ml pepstatin and 0.1 unit/ml aprotinin). Lysates were centrifuged at 13,000 × g for 10 min at 4°C and the supernatants were collected and assayed for protein concentration with the Bradford assay method (Bio-Rad).
Histones were acid extracted from nuclei with 0.4 N HCl and precipitated with trichloroacetic acid, followed by washing with ice cold acetone containing 0.006% HCl, and then with pure ice cold acetone. The resulting pellets were air-dried, dissolved in a minimal volume of sterile distilled water and the 
RNA isolation & real-time PCR
Total RNA was extracted using the guanidinium thyocianate method. Starting from equal amounts of RNA, cDNA used as template for amplification in the real-time PCR (5 μg), was synthesized by the reverse transcription reaction using RevertAid Minus First Strand cDNA Synthesis Kit from FermentasThermo Scientific (Burlington, ON, Canada), using random hexamers as primers, according to the manufacturer's instructions. The real-time reverse transcription-PCR was performed using the double-stranded DNA-binding dye SYBR Green PCR Master Mix (Fermentas-Thermo Scientific) on an ABI GeneAmp 7000 Sequence Detection System machine, as described by the manufacturer. The instrument, for each gene tested, obtained graphical Cycle threshold values automatically. Triplicate reactions were performed for each marker and the melting curves were constructed using Dissociation Curves Software (Applied Biosystems, CA, USA), to ensure that only a single product was amplified. The primers sequences are reported in Supplementary Table 1 . In this study, we used 18S rRNA as reference gene, based on data in literature [25, 26] and our results (not shown) that indicate 18S rRNA as more reliable than GAPDH and ACTB for comparative analysis of transcriptional expression in hypoxia versus normoxia.
Statistical analysis
Statistical evaluation of the differential analysis was performed by one-way ANOVA and Student's t-test.
Results
ESR2 expression positively correlates with KDM6B expression in MPM tumors
As previously reported [12] , we performed an in silico analysis of microarray data on biopsies from MPM patients to generate an ESR2 expression meta-signature. In brief, two publicly available microarray geneexpression datasets from 93 MPM tumors, GSE 2549 (n = 40) and GSE 29354 (n = 53) were analyzed. Raw data were preprocessed and normalized using Robust Multichip Average method, and the median expression level for the probe set 210780 was used to stratify the samples into "high ESR2" or "low ESR2" expressors. Following analysis to adjust for batch variance and find contrast between the two classes of upregulated genes in the "high ESR2" group (false discovery rate [FDR] adjusted p ≤ 0.05, fold-change ≥2) we identified the KDM6B gene. This positive correlation between ESR2 and KDM6B expression was also observed in REN and MSTO-211H cells, derived from epithelioid and biphasic MPM, respectively. Real-time PCR and western blot data revealed that MSTO-211H cells express significantly lower levels of ESR2 and KDM6B, compared with REN cells ( Figure 1A & B) ; whereas both cell lines express equal levels of EZH2 ( Figure 1A) . In order to validate data observed in tumors, we investigated whether KDM6B overexpression in MSTO-211H cells and its silencing in REN cells could affect ERβ expression. Real-time PCR ( Figure 1C ) and western blot analyses ( Figures 1D ) document a significant increase in both ESR2 transcription and translation in KDM6B overexpressing MSTO-211H cells. By contrast, ESR2 mRNA and protein were downregulated in KDM6B silenced REN cells (Figure 1E & F) . In both conditions the levels of EZH2 remained unchanged. The tri-methylation status of histone H3 at lysine 27, shown in Figure 1D 
Hypoxia-induced ERβ expression in MSTO-211H cells depends on KDM6B
We recently published that the estrogen receptor negative MSTO-211H cells express ERβ and acquire an epithelioid phenotype when cultured under hypoxic conditions [13] . Here we assessed the role of KDM6B in ERβ induction in response to hypoxia. Real-time PCR and western blot analyses (Figure 2A & B) provided evidence that both KDM6B and ERβ expression increased when MSTO-211H cells were grown under chronic hypoxic conditions (as shown in Supplementary Figure 1C , similar induction was observed in H2596 cells). Furthermore, hypoxia was found to induce an increase in KDM6B activity, as confirmed by reduced histone H3K27 tri-methylation ( Figure 2B ). In KDM6B silenced cells ERβ expression and H3K27 tri-methylation returned to control levels ( Figure 2B ). Of note, EZH2 expression was not regulated either by hypoxia or KDM6B silencing (Figure 2A) . Thus, through gene silencing, we demon- (Figure 2A & B) . Phase contrast images of MSTO-211H cells show that the epithelioid phenotype acquired in hypoxia was also dependent on KDM6B expression ( Figure 2C ).
Parallel induction of EPAS1, KDM6B and ESR2 was observed in MSTO-211H cells grown as spheroids for 5 days (Figure 2D ). The presence of KDM6B and ERβ expression in the hypoxic core of the spheroids was confirmed by immunofluorescence staining with specific anti-HIF-2α, KDM6B and ERβ antibodies ( Figure 2E ).
KDM6B induction in hypoxia depends on HIF-2α
As KDM6B was recently described to be regulated by HIF-2α [27] and as we observed a switch from HIF1A to EPAS1 expression from rapid to long-term hypoxia ( Figure 3A) , we decided to test the effect of EPAS1 silencing on KDM6B expression in MSTO-211H cells cultured under chronic hypoxic conditions. Data, shown in Figure 3B , confirm that the induction of KDM6B expression was dependent on HIF-2α. The silencing of EPAS1 was confirmed by quantitative RT-PCR ( Figure 3C ).
ERβ expression is maintained when cells return to normoxia if treated with the selective agonist KB9520
The described change in cell morphology and gene expression that occurred in MSTO-211H cells grown in hypoxia was reversed upon reoxygenation; the MSTO-211H cells reacquired the spindle-shaped morphology when returned from hypoxia to normoxia ( Figure 4A ). Reoxygenation also decreased expression of KDM6B and ERβ at both mRNA and protein levels, including the activity of KDM6B (Figure 4B & C) . In all conditions, no changes in EZH2 expression occurred ( Figure 4B) . Interestingly, when the selective ERβ agonist KB9520 was added to cells, during post hypoxia recovery, the epithelioid cell morphology ( Figure 5A ) and the expression of both KDM6B and ERβ was maintained ( Figure 5B & C) . Surprisingly, also the expression of EPAS1 was maintained by KB9520 treatment despite normoxia ( Figure 5D ). Moreover, cell treatment with KB9520 during reoxygenation resulted in increased expression of EP300 and HIC1, together with significantly reduced expression of SIRT1 ( Figure 5D ).
Discussion
In this study we describe a positive correlation between ESR2 and KDM6B expression in tumors and cell lines derived from MPM patients. Furthermore, we describe significantly increased KDM6B and ERβ expression levels in response to hypoxia in cells derived from biphasic MPM.
As tumors grow, the inadequate blood supply results in regions where the concentration of oxygen is severely reduced relative to normal tissue. Hypoxic conditions induce cellular adaptive response including changes in metabolism, from oxidative phosphorylation to glycolysis, autophagy and partial shut-down in highenergy consumption processes [18] . Hypoxia is a common feature in MPM. A pilot study performed with [F-18] fluoromisonidazole (FMISO) PET-CT analysis has provided evidence of significant areas of hypoxia in MPM dominant tumor masses [28] . Another study has described carbonic anhydrase IX (CAIX) positivity, proposed to serve as a surrogate marker of hypoxia, to be predominant in epithelioid MPMs, while not expressed in sarcomatoid and sarcomatoid areas of biphasic MPMs [29] .
Differently from other tumors in which the hypoxic condition induces epithelial-mesenchymal transition and invasion [30] [31] [32] , we have recently described that hypoxia causes, in cells derived from biphasic MPM, the switch from spindle to epithelioid phenotype with increased E-cadherin expression and reduced growth rate [13] . Slow growth of MPM cells under hypoxia has also been reported and interpreted by other authors as a consequence of rapidly exhausted glucose in the medium [33] .
We have described that the estrogen receptornegative MSTO-211H cells cultured as spheroids in vitro or as tumor mass in vivo transiently expressed the tumor suppressor ERβ. ERβ expression was maintained and cell growth was significantly inhibited when the receptor was activated by a selective agonist [13] .
The response to hypoxia is primarily mediated by the family of HIF transcription factors, regulated by the oxygen-sensing HIF hydroxylases [34] [35] [36] .
While the HIF system is the major factor affecting gene expression changes associated with oxygen concentrations, it is feasible that epigenetic changes, both dependent and independent of HIF pathways, also have significant implications in transcriptional regulation and cellular adaptation at different conditions [37] . Changes in epigenetic marks, including lysine methylation of histones, have been observed in development and in disease states where hypoxia is known to be an important feature. The distribution of histone methylation across the genome is an important factor for gene transcription [37, 38] . Histone-lysine methylation is dynamically regulated by histone methyltransferases (KMTs) and histone demethylases (KDMs).
The H3K27 methyltransferase EZH2, part of the PRC-2, controls dimethylation and trimethylation of H3K27 (H3K27me2/3). EZH2 has been described to be overexpressed in approximately 85% MPMs relative to normal pleura, correlating with diminished patient survival. Knockdown of EZH2 decreases global H3K27me3 levels and significantly inhibits proliferation, migration, clonogenicity and tumorigenicity of MPM cells [39, 40] . More recently, it has been reported that BAP1 (BRCA1 associated protein-1) loss in mice resulted in increased H3K27 trimethylation, elevated EZH2 expression and enhanced repression of PRC2 targets. Authors describe that BAP1-mutant MPM cells are sensitive to EZH2 pharmacologic inhibition in 2D and 3D culture, while BAP1 wild-type cells, among them MSTO-211H, do not respond [40] .
Here we describe, independently from EZH2 expressed levels, that the increased expression of KDM6B is responsible for induced expression of the tumor suppressor ERβ and the maintenance of an epithelioid phenotype in MSTO-211H cells. However, whether KDM6B has a direct or indirect effect on ERβ promoter activity is not apparent from presented data and would require additional studies.
Recently, KDM6B was identified as an HIF target gene and thus upregulated in hypoxic conditions [41] . Moreover, results of co-immunoprecipitation (Co-IP) and knockdown experiments indicate that KDM6B can form complex with HIF-2α or HIF-1α and is a potential regulator of HIF-2α target genes [27] . HIF-2α was initially identified as the endothelial PAS domain protein (EPAS1), but it is also expressed in many other tissues and exert a widespread role in driving the response during chronic hypoxia exposure [42] . Our data demonstrate that KDM6B is under the control of HIF-2α and is important for the expression of hypoxia response tumor suppressor genes in MPM. Differently from other tumor types, where EZH2 expression has been described to be controlled by hypoxia through HIF response elements in its promoter [43, 44] , we did not observe significant variations in its expression in response to different oxygen availability.
In vivo, local tumor cells are exposed to chronic hypoxia, but also to reoxygenation during the process of invasion and metastasis.
In our experimental setting, cellular hypoxia was induced by placing cultured tumor cells in an environmentally-controlled chamber in which oxygen levels in the gas phase were maintained at 1%, but with sufficient glucose and growth-promoting factors available.
As a result, cells became quiescent but resumed active proliferation and the spindle-shaped phenotype upon re-establishment of normoxic conditions. Importantly, ERβ activation during reoxygenation was essential for maintaining the less aggressive epithelioid phenotype in MPM cells.
Retention of high levels of EPAS1 expression in cells treated with KB9520 during reoxygenation is suggestive of persistent pseudo-hypoxic state. We have previously described that ERβ activation increased the acetylation of electron transport chain proteins compromising the mitochondrial functions [12] . Increased acetylation could in part be explained by the observed inverse regulation of SIRT1 and EP300 expression. Furthermore, the switch between SIRT1 and EP300 could be responsible for a general increase in protein acetylation and epigenetic modulation of gene transcription. Furthermore, coherently with SIRT1 downregulation, here we report the increase in HIC1 expression. HIC1, a tumor suppressor gene frequently deleted or epigenetically silenced in human cancers, encodes a transcriptional repressor [45, 46] . SIRT1 was the first characterized HIC1 target gene [47] . In mesothelioma cells, HIC1 has been described to be upregulated following knockdown of EZH2 and decreased H3K27Me3 levels within its promoter [48] . We speculate that the observed downregulation of SIRT1 may be due to increased KDM6B/HIC1 expression.
Conclusion & future perspective
Biphasic MPM, characterized by a mix of epithelioid and sarcomatoid cells, is the second most common type of the disease. Better results from treatment are observed in biphasic patients with a lower number of sarcomatoid cells. This study describes that the hypoxic microenvironment favors sarcomatoid to epithelioid phenotype transition and ERβ expression. Importantly, we demonstrate that by targeting ERβ with a selective agonist it is possible to maintain the epithelioid phenotype during reoxygenation. Further research will help to understand the multifaceted roles of the hypoxic tumor microenvironment that will help to drive the development of novel and more efficacious therapeutic approaches.
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